Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Genmab a::S symbols : BHC save search
Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others
Published: 2022-04-28 (Crawled : 21:00) - prnewswire.com
GNMSF | $282.004 -3.13% 0
|
Health Technology
|
| O: 2.93%
H: 1.47%
C: 1.33%
GLAXF | $20.2 0.65% -14.18% 0
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: -0.99%
NVS | $92.69 -1.82% 100K
|
Health Technology
|
| O: 0.19%
H: 0.59%
C: -1.36%
GSK | $39.765 -1.82% 260K
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
BMY | $48.51 0.48% 0.47% 8.6K
|
Health Technology
|
| O: -3.61%
H: 3.02%
C: 2.02%
BHC | $8.52 -1.28% 48K
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
GMAB | $29.0 -1.73% 19K
|
Health Technology
|
| O: 1.4%
H: 0.82%
C: -1.07%
t-cell
Gainers vs Losers
| 43% | 57% |
Top 10 Gainers
TPET | $0.4801 107.75% 16M
|
n/a
WISA 4 | $3.17 81.14% 36M
|
Electronic Technology
PALI | $7.41 78.13% 14M
|
Manufacturing
SPCB | $0.4278 55.0% 17M
|
Electronic Technology
PRSO | $1.79 40.95% 25M
|
Manufacturing
JAGX | $0.1668 40.4% 110M
|
Health Technology
MCBC | $13.84 39.38% 450K
|
Finance
SNGX | $0.5155 33.52% 3.9M
|
Health Technology
SNPO | $10.57 29.85% 570K
|
ITCI | $80.21 23.86% 2M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.